Chandigarh (Haryana) [India], January 19 (ANI): Haryana reported 119 new COVID-19 cases on Monday taking the total number of cases in the state to 2,66,428, according to the state health department.
Chandigarh (Haryana) [India], January 3 (ANI): Haryana on Saturday reported 2 deaths and 218 new COVID-19 cases, according to the State Health Department.
Gurugram (Haryana) [India], December 23 (ANI): Haryana Home and Health Minister Anil Vij, who is undergoing treatment for COVID-19, has been shifted from the Intensive Care Unit (ICU) to a room on Wednesday.
Rohtak (Haryana) [India], December 15 (ANI): Haryana Health Minister Anil Vij, who had tested positive for coronavirus after taking a trial dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' has been referred to Medanta Hospital Gurugram on Tuesday.
Chandigarh [India], November 20 (ANI): All government and private schools in Haryana will remain closed till November 30 in view of COVID-19 situation, the state government said on Friday.
Ambala (Haryana) [India], November 20 (ANI): Haryana Health Minister Anil Vij was administered a trial dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' at a hospital in Ambala on Friday.
Chandigarh (Haryana) [India], October 12 (ANI): Haryana reported 1065 new cases of COVID-19 on Sunday, taking the total cases in the state to 1,42,155.
Chandigarh [India], October 4 (ANI): Haryana on Saturday reported 1,188 COVID-19 cases, 1,542 recoveries and 25 deaths, according to the State Health Department.
New Delhi [India], September 23 (ANI): Union Home Secretary Ajay Kumar Bhalla on Wednesday said that Haryana has performed "outstandingly in COVID-19 management" but the officers' concerned need to be cautious owing to the upcoming festive season, the state government said on Wednesday.
Chandigarh (Haryana) [India], September 11 (ANI): As many as 2,388 new COVID-19 cases and 25 deaths were reported in Haryana on Friday, taking the state's count of coronavirus cases to 88,332.
Rohtak (Haryana) [India], September 8 (ANI): Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech's COVID-19 vaccine.